Synairgen on backing for pivotal clinical trial

Показать описание

Synairgen chief executive Richard Marsden discusses fundraising efforts to support a pivotal Phase 2 clinical trial. #ClinicalTrial #RespiratoryHealth #SNG001 #Medicine #Healthcare #MedicalResearch #PatientCare #Synairgen

Proactive Investors